“We take [compliance with ClinicalTrials.gov] requirements seriously,” says Miah Jung, PharmD, a pharmacologist with the U.S. Food and Drug Administration (FDA). While the FDA “hopes for voluntary compliance,” the agency […]
Clinical trials published in high-profile medical journals rarely report on income or other key sociodemographic characteristics of study participants, according to a new study that suggests these gaps may create […]
The moral argument is self-evident and powerful, but improving diversity in the clinical trial patient population and workforce is also the right thing to do from a scientific perspective, says […]
“Whatever we could do to make it easier for patients, we tried to do,” Patrick Floody, senior director of global study strategy and optimization at Regeneron, told attendees of the […]
U.S. Representatives Bobby L. Rush (D-Ill.) and Brian Fitzpatrick (R-Pa.) have introduced the Long-term Opportunities for Advancing New Studies (LOANS) for Biomedical Research Act (H.R. 3437), new bipartisan legislation that […]